Proponents say direct-to-consumer sales by drugmakers cut out intermediaries that add needlessly to prices. Detractors see ethical issues and prices that are still too high for many patients.

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

Insurance coverage for weight-loss drugs has recently increased, but typically only covers branded versions, according to ...

Eli Lilly and Company (NYSE:LLY) is one of the 12 stocks that will make you rich in 10 years. On June 23, Truist Securities ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 ...

Grey market grows for cheap weight-loss drugs imported from China Some users try small doses of substances not yet approved ...

The Health Secretary’s 10-year plan includes proposals to bring down the cost of weight-loss drugs so more patients can get ...

The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, UnitedHealth Group and several other drug manufacturers accusing the companies of deliberately inflating insulin ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

The HHS wants to move oversight of the controversial drug discount program to the CMS, which has a more aggressive history ...